Antibiotic consumption monitoring at the Institute of Otorhinolaryngology and Maxillofacial Surgery--Clinical Center of Serbia in 2001-2003.
BACKGROUND
At the Clinical Center of Serbia (CCS), which includes 21 Institutes and 6 Centers, approximately 10% of the total annual budgetary funds is spent on the drugs. During the studied period, it was estimated that 0.5% of the above amount has been spent at the Institute for Otorhinolaryngology and Maxillofacial surgery (Institute for ORL and MFS), Clinical Center of Serbia. The aim of this study was to find out if these antibiotics had been used rationally by the monitoring of antibiotics in relation to the number of inpatients, and by the 5 most frequent diagnoses.


METHODS
The authors monitored the three-year consumption of antibiotics for inhospital treated patients during the period 2001-2003. Data were obtained from the itemized quarterly report on the consumption by the Central Pharmacy of the CCS.


RESULTS
The results were statistically analyzed and presented in percentages and Defined Daily Dosages (DDD) for each group of the antibiotics. The results were analyzed in accordance with the World Health Organization Recommendations and the Guidelines.


CONCLUSIONS
The authors concluded that antibiotics were adequately used at the Institute for ORL and MFS-CCS. The most commonly used antibiotics for gram-positive infections were those from the penicillin and cephalosporin groups. According to the international trends and recommendations, the selected therapy was rational and the antibiotics consumption was cut down during the observed three-year period. It was a true confirmation that the recommendations for the rational antibiotics consumption had been fruitful (produced good results).
Kastratović
Dragana A
DA
Clinical Center of Serbia, Center of Clinical Pharmacology, Belgrade, Serbia and Montenegro. maca.kastratovic@kcs.ac.yu
Dukić
Vojko B
VB
Majstorović
Branislava M
BM
Komrska
Jan J
JJ
Gajić
Milan M
MM
Marković
Srdan Z
SZ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D006782:Hospitals, Special; D006801:Humans; D019647:Oral Surgical Procedures; D013517:Otorhinolaryngologic Surgical Procedures; D015022:Yugoslavia
D000900:Anti-Bacterial Agents